by Team Small News | Apr 15, 2025 | Glenmark, Pharma, Sun Pharma, Zydus
Three major Indian pharmaceutical companies, Sun Pharma, Zydus, and Glenmark, have issued recalls of their products in the United States due to manufacturing issues. The recalls were announced by the US Food and Drug Administration (FDA) and cover a range of products,... by Team Small News | Apr 11, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals has received a nod from a CDSCO (Central Drugs Standard Control Organization) panel to conduct clinical trials in India for its new investigational drug combination, Glycopyrronium, Fluticasone Furoate, Vilanterol Powder for Inhalation. This... by Team Small News | Apr 7, 2025 | Glenmark, Pharma
However, I don’t see any content to summarize. The provided text only mentions the use of cookies and a link to a Cookie Policy and Cookie Settings, but it does not contain any actual content about Glenmark Pharma naming an individual as president. Can you... by Team Small News | Apr 3, 2025 | Glenmark, Pharma
Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, is a India-based company that develops and manufactures non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The company provides contract development and... by Team Small News | Apr 3, 2025 | Glenmark, Pharma
Here is a summary of the content in 400 words: Glenmark Pharmaceuticals, USA has launched Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial). This product is bioequivalent and therapeutically equivalent to the... by Team Small News | Apr 2, 2025 | Glenmark, Pharma
Glenmark has announced the launch of its generic version of Mylan’s Vancomycin Hydrochloride for Injection, which is now available in three concentrations: 750 mg/vial, 1.25 g/vial, and 1.5 g/vial (Single-dose vial). According to IQVIA, the market value of...